ReWalk Robotics Ltd. (NASDAQ:RWLK) dropped 7.5% during trading on Monday . The company traded as low as $6.62 and last traded at $6.80, with a volume of 58,983 shares trading hands. The stock had previously closed at $7.35.

RWLK has been the topic of a number of research reports. Zacks Investment Research raised shares of ReWalk Robotics from a “hold” rating to a “buy” rating and set a $11.00 price objective on the stock in a research note on Tuesday, May 10th. Jefferies Group reaffirmed a “buy” rating and set a $16.00 price target on shares of ReWalk Robotics in a research note on Sunday, May 8th.

The stock’s market cap is $84.12 million. The stock has a 50 day moving average of $7.18 and a 200-day moving average of $9.46.

ReWalk Robotics (NASDAQ:RWLK) last issued its quarterly earnings data on Thursday, May 5th. The medical device company reported ($0.48) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.60) by $0.12. The company had revenue of $2.06 million for the quarter, compared to the consensus estimate of $1.56 million. During the same quarter in the prior year, the firm earned ($0.48) earnings per share. ReWalk Robotics’s revenue for the quarter was up 224.6% compared to the same quarter last year. Equities analysts predict that ReWalk Robotics Ltd. will post ($2.11) earnings per share for the current fiscal year.

In other ReWalk Robotics news, Director Jeff Dykan sold 27,022 shares of the business’s stock in a transaction dated Thursday, May 26th. The shares were sold at an average price of $8.69, for a total value of $234,821.18. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, major shareholder Scp Vitalife Partners (Israel) sold 4,043 shares of the business’s stock in a transaction dated Friday, May 20th. The stock was sold at an average price of $9.09, for a total transaction of $36,750.87. The disclosure for this sale can be found here.

An institutional investor recently bought a new position in ReWalk Robotics stock. EAM Investors LLC purchased a new stake in ReWalk Robotics Ltd. (NASDAQ:RWLK) during the fourth quarter, according to its most recent filing with the SEC. The institutional investor purchased 93,333 shares of the medical device company’s stock, valued at approximately $1,351,000. EAM Investors LLC owned about 0.77% of ReWalk Robotics at the end of the most recent quarter.

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk. The Company offers ReWalk, an exoskeleton that uses its tilt-sensor technology, and an on-board computer and motion sensors to drive motorized legs that power movement.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.